CSL To Pay $64M To Escape Blood Plasma Antitrust Suit
Australian medical product giant CSL Ltd. announced Monday that it will pay $64 million to escape a consolidated antitrust class action in which hospital groups claim it took part in a...To view the full article, register now.
Already a subscriber? Click here to view full article